Company intelligence / Profile preview

Armonica Technologies

Carlsbad, California, United Statesarmonicatech.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Armonica Technologies has developed a proprietary direct optical long-read DNA sequencing technology that enables single-molecule detection of nucleotides and epigenetic modifications without the need for amplification or labeling. The technology has demonstrated effectiveness in laboratory settings but is still being optimized for scalable manufacturing. It aims to provide faster, more comprehensive genomic data than current methods, with potential to accelerate diagnostics in precision medicine.

Therapeutic areas: Oncology
Modalities: Genomic sequencing (long-read DNA sequencing)Epigenetic analysis
Industry: Molecular Diagnostics

Partnerships

University of New Mexico Center for High Technology Materials (CHTM)Sandia National LaboratoriesLos Alamos National Laboratory

Beyond the preview

Go deeper on Armonica Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Armonica Technologies.

Explore the full profile